OTC : CVALF

Covalon Technologies Ltd.

$1.65 USD

$0.03 (1.85%)

Volume
1.7K
Average Volume
5.84K
Market Capitalization
$45.57M
P/E Ratio
38.53
Dividend Yield
6.52%
Price Target
Year High
$2.14
Year Low
$1.16
Day High
—
Day Low
—
Payout Ratio
$2.52
Current Ratio
$7.57
Company Overview

OTC

Brent Ashton

Biotechnology

Healthcare

CVALF

105

CA

USD

https://www.covalon.com

+1 905 568 8400

22282D302

0001789397

Liquidity Metrics

0.06

7.57

5.85

4.45

2.52

Sales & Valuation

$32.82M

1.94

2.27

13.60

0.17

Profitability

$0.0739

$2.06M

5.02%

5.02%

5.72%

4.95%

P/E Metrics

38.53

-0.67

-0.67

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

7.67

5/9

$24.49M

$33.27M

$5.18M

$1.14M

Key Metrics (TTM)

$47.62M

1.46

22.78

7.57

5.72%

3.82%

2.63%

7.49%

$1.16

126 days

Company Executives
Name Title
Greg Leszczynski Vice President of Human Resources
Valerio DiTizio Co-Founder, Chief Scientific Officer & Vice President
Gerry Arambula President of Covalon Technologies AG Ltd.
Hamed Abbasian Vice President of Business Development
Katie Martinovich Chief Financial Officer
Brent Ashton Chief Executive Officer & Director
Kimberley Crooks COO & Director
Saleha Assadzada Executive Assistant to the Chief Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About Covalon Technologies Ltd. (OTC:CVALF) Stock

Covalon Technologies Ltd. is a global medical technology firm specializing in the innovation, production, commercialization, and licensing of medical solutions across the United States, Canada, Europe, the Middle East, Asia, and Latin America. The company's operations are built upon three distinct proprietary technological platforms. The first, a collagen matrix platform, underpins a family of products aimed at treating chronic and infected wounds such as diabetic, pressure, and venous ulcers, as well as donor/graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first- and second-degree burns. Secondly, an antimicrobial silicone adhesive platform is utilized in various pre- and post-surgical and vascular access products, specifically engineered to eli ... minate bacteria or yeast on contact, thus providing broad-spectrum antimicrobial activity. The third is a medical coating platform, an advanced process employing photo-polymerization to create active grafting sites where new polymer chains are initiated and propagate from the surface of existing medical devices. Covalon's product offerings include wound care dressings, surgical and peri-operative solutions, and infection management tools. These products, sold under the Covalon brand, are distributed through both the company's direct sales force and third-party networks to a wide range of clients, including hospitals, wound and burn care centers, acute and extended care facilities, home health agencies, and physicians' offices. The company's corporate headquarters are located in Mississauga, Canada.

Covalon Announces Appointment of New Director and DSU Grants

2026-06-09 13:00:00

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the appointment of Dr. Murray Miller to its Board of Directors (“Board”) as an independent director subject to TSX Venture Exchange approval. Dr. Miller graduated as a Medical Doctor from the University of Manitoba in 1982. He completed his residency in Radiology at the University of Toronto. Dr. Miller has served as a.

Covalon Technologies Ltd. (COV:CA) Q2 2026 Earnings Call Transcript

2026-05-21 12:50:43

Covalon Technologies Ltd. (COV:CA) Q2 2026 Earnings Call Transcript

Covalon Reports 2026 Second Quarter Results

2026-05-21 07:00:00

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company's profile at www.sedarplus.ca. Brent Ashton, Covalon's Chief Executive Officer, commented, “Covalon.

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results

2026-05-14 13:00:00

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://events.q4inc.com/attendee/485973962 To listen.

Frequently Asked Questions

What is the current Covalon Technologies Ltd. (CVALF) stock price?

Covalon Technologies Ltd.(OTC:CVALF) stock price is $1.65 in the last trading session. During the trading session, CVALF stock reached the peak price of $2.14 while $1.16 was the lowest point it dropped to. The percentage change in CVALF stock occurred in the recent session was 1.85% while the dollar amount for the price change in CVALF stock was $0.03.

CVALF's industry and sector of operation?

The OTC listed CVALF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of CVALF?

Greg Leszczynski | Vice President of Human Resources
Valerio DiTizio | Co-Founder, Chief Scientific Officer & Vice President
Gerry Arambula | President of Covalon Technologies AG Ltd.
Hamed Abbasian | Vice President of Business Development
Katie Martinovich | Chief Financial Officer

How many employees does CVALF have?

Number of CVALF employees currently stands at 105. CVALF operates from 1660 Tech Avenue, Mississauga, ON L4W 5S7, CA.

Link for CVALF official website?

Official Website of CVALF is: https://www.covalon.com

How do I contact CVALF?

CVALF could be contacted at phone #+1 905 568 8400 and can also be accessed through its website. CVALF operates from 1660 Tech Avenue, Mississauga, ON L4W 5S7, CA.

How many shares of CVALF are traded daily?

The average number of CVALF shares traded daily for last 3 months was 5.84K.

What is the market cap of CVALF currently?

The market value of CVALF currently stands at $45.57M with its latest stock price at $1.65